Clinical Trial Update: cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China

View source ↗

Summary

This entry provides an update on a Berry Genomics trial using cSMART Liquid Biopsy to dynamically monitor non-small cell lung cancer patients in Inner Mongolia,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Berry Genomics Co., Ltd. | Conditions: Nonsmall Cell Lung Cancer, Adenocarcinoma | Status: UNKNOWN